Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Betnecip 4mg/ml Injection

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Betamethasone (4mg/ml)

Overview Betnecip 4mg/ml Injection

Steroidal medication Betnecip, a 4mg/ml injectable solution, treats allergic reactions by suppressing inflammation (characterized by redness, soreness, warmth, and swelling). Its rapid action necessitates administration by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician; consistent use is crucial for optimal results. Discontinue use only upon medical advice, regardless of symptom improvement. Common side effects include mood alterations, depressive symptoms, gastrointestinal discomfort, and injection site reactions (pain, redness, swelling). Report any bothersome side effects to your doctor. Prior to use, disclose any drug allergies or liver conditions. Its use is contraindicated during pregnancy; pregnant and lactating individuals require medical consultation before administration.

Primary Ingredients of Betnecip 4mg/ml Injection

No text provided to rephrase.

Uses of Betnecip 4mg/ml Injection

Managing Allergic Reactions

Major Benefits of Betnecip 4mg/ml Injection:

This medication will be administered by your healthcare provider; please do not attempt self-medication.

Common Side effects of Betnecip 4mg/ml Injection:

  • Depression
  • Reduction in bone density
  • Upset stomach

How to use Betnecip 4mg/ml Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Betnecip 4mg/ml Injection works:

Celestone Soluspan 4mg/ml Injection is a corticosteroid that inhibits the synthesis of specific inflammatory mediators, thus reducing symptoms such as redness and swelling associated with allergic reactions.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Betnecip 4mg/ml Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Betnecip 4mg/ml Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Betnecip 4mg/ml Injection while breastfeeding is likely safe. Available human data indicate minimal infant risk associated with this medication.

DrivingDrivingSAFE

Administration of Betnecip 4mg/ml Injection typically does not impair driving ability.

KidneyKidneySAFE IF PRESCRIBED

The use of Betnecip 4mg/ml Injection in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, though this is based on limited information. Physician consultation is recommended. Routine monitoring of renal function is advisable during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Betnecip 4mg/ml Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Betnecip 4mg/ml Injection :

Should you forget a Betnecip 4mg/ml Injection dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Betnecip 4mg/ml Injection

LabelValue
Chemical Type Corticosteroids
Developing Habits No.
Treatment Category Breathing
Behavioral Class Corticosteroids

FAQs on Betnecip 4mg/ml Injection

Betnecip 4mg/ml Injection, a corticosteroid, treats various conditions. Its uses include allergic conditions (asthma, arthritis, Crohn's disease, ulcerative colitis), blood disorders, and adrenal gland diseases. It also alleviates swelling, redness, itching, and allergic reactions associated with these conditions.
Betnecip 4mg/ml Injection takes effect within hours, though peak effectiveness typically occurs between two and seven days after the initial dose.
Betnecip 4mg/ml Injection dosage is determined by your doctor based on your condition's severity, your weight, and the specific illness. The usual frequency is once or twice daily, but more frequent administration (3-4 times daily) might be necessary for severe cases. Self-administration is not recommended; always consult your doctor before using Betnecip 4mg/ml Injection.
Betnecip 4mg/ml Injection must be administered by or under the direct supervision of a healthcare professional; self-administration is strictly prohibited. Injection sites typically include muscles, joints, or the affected area. Dosage is determined by your doctor based on your condition and weight. For optimal results, adhere strictly to your doctor's instructions.
Betnecip 4mg/ml Injection may cause skin burning, itching, dryness, redness around the mouth, excessive hair growth, skin lightening or discoloration, and thinning. Some users may also experience stomach upset, mood changes, or behavioral changes. Consult your doctor if any side effects are bothersome or persistent.
Weight gain is a possible side effect of Betnecip 4mg/ml Injection, particularly with high doses, prolonged use, or repeated short treatments. Consult your doctor if you gain weight while using this medication.
Betnecip 4mg/ml Injection
4
MRP 4
2% off